TLPH

Talphera Inc

0.46

-0.01-1.67%

After Hours: 0.4800 +0.0198 +4.30%17:55 06/30 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE0.4600/0.4680

TODAY RANGE0.4600-0.4800

VOL46.26K

MARKET CAP9.44M

52 WEEK RANGE0.4300-1.190

AVG VOL (3M)47.45K

% TURNOVER0.23%

TURNOVER--

P/E (TTM)-1.0365

% RANGE4.27%

EPS(TTM)-0.4440

P/E(FORWARD)-0.8367

P/B1.405

BVPS0.3275

DIVIDEND--

P/S11.98

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP9.19M

SHARES OUTSTANDING20.50M

NEXT EARNINGS08/12-08/18

FREE FLOAT19.97M

LOT SIZE1

EX-DATE10/26/2022

News

Press Releases

Financial Reports

Profile

TipRanks·06/05 21:31
Talphera Granted Extension for Nasdaq Compliance
TipRanks·05/16 16:15
Talphera’s Strategic Advancements and Financial Stability Reinforce Buy Rating
TipRanks·05/16 01:44
Talphera, Inc. Earnings Call: Strategic Adjustments and Financial Progress
TipRanks·05/15 04:21
Talphera, Inc. Reports Q1 2025 Financial Results
Reuters·05/15 02:22
Talphera Inc reports results for the quarter ended March 31 - Earnings Summary
Seeking Alpha·05/15 01:02
Talphera outlines accelerated NEPHRO CRRT study timeline with completion targeted by end of 2025, supported by new site activations and $14.8M financing
TipRanks·05/14 20:17
Talphera reports Q1 EPS (10c), consensus (14c)
TipRanks·05/14 20:17
Talphera sees 2025 expenses $17M-$19M
Seeking Alpha·05/14 20:07
Talphera GAAP EPS of -$0.10 beats by $0.05
Seeking Alpha·05/14 14:00
Here are the major earnings after the close today
TipRanks·05/02 21:20
Talphera files to sell 3.41M shares of common stock for holders
NASDAQ·04/04 16:00
Talphera (TLPH) Upgraded to Buy: What Does It Mean for the Stock?
TipRanks·04/04 02:04
Talphera CEO Makes Bold Move with Major Stock Purchase!
TipRanks·04/02 16:10
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks·04/02 00:02
Talphera, Inc. Earnings Call: Progress Amid Challenges

Same Industry

Name/Symbol

Change%

Price

McKesson

MCK

+0.96%

732.78

Biogen Inc

BIIB

-0.39%

125.59

Amgen Inc

AMGN

+0.75%

279.21

Shire

SHPG

179.20

Bristol-Myers Squibb Company Celegne Contingent Value Rights

CELG-RT

0.00%

0.0250

Lilly Eli & Co

LLY

+0.53%

779.53

Celgene

CELG

108.24

Therapeuticsmd Inc

TXMD

+3.57%

1.16

Johnson & Johnson

JNJ

+0.22%

152.75

Abbvie Inc

ABBV

+1.82%

185.62

Zoetis Inc

ZTS

-0.14%

155.95

Gilead Sciences Inc

GILD

+0.18%

110.87

Novo-Nordisk A/S

NVO

+0.74%

69.02

Bristol-Myers Squibb Co

BMY

-0.13%

46.29

Alexion Pharms

ALXN

+1.70%

182.50

Pfizer

PFE

+0.21%

24.24

Sanofi FR

SNY

+0.96%

48.31

Sanofi FR

GCVRZ

0.00%

0.8711

Novartis

NVS

+0.83%

121.01

Dr Reddys Labs

RDY

-0.27%

15.03

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.